Author

Falk Clemens Thiel

Observed names: F C Thiel, F Thiel, F. C. Thiel, F. Thiel, F.C. Thiel, Falk C Thiel, Falk C. Thiel, Falk Thiel, Thiel, F.C., Thiel, Falk, Thiel, Falk Clemens 1972-

Institution: Alb Fils Kliniken

Observed institutions: Philipps University of Marburg, Friedrich-Alexander-Universität Erlangen-Nürnberg, Universität Ulm, Johannes Gutenberg University Mainz, QIMR Berghofer Medical Research Institute, University of Münster, Moffitt Cancer Center, Medizinische Hochschule Hannover, Universitätsklinikum Erlangen, Düsseldorf University Hospital, Alb Fils Kliniken, University Medical Center Hamburg-Eppendorf, Jena University Hospital, Kliniken Essen-Mitte, Comprehensive Cancer Center Erlangen, University Hospital Ulm, Martin Luther University Halle-Wittenberg, University of Göttingen, University of Tübingen

OpenAlex ID: A5108788654

A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2

2009 · Australian Cancer (Ovarian) Study, Honglin Song, et al. · Nature Genetics · 313

PDF

Common variants at 19p13 are associated with susceptibility to ovarian cancer

2010 · the Australian Ovarian Cancer Study Group, Kelly L Bolton, et al. · Nature Genetics · 246

Adjuvant Therapy in Lymph Node–Positive Vulvar Cancer: The AGO-CaRE-1 Study

2015 · Sven Mahner, Julia Jueckstock, et al. · JNCI Journal of the National Cancer Institute · 224

PDF

Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label, phase 3 trial

2020 · Jacobus Pfisterer, Catherine M Shannon, et al. · The Lancet Oncology · 166

PDF

Estrogen and progesterone receptors: from molecular structures to clinical targets

2009 · Stephan Ellmann, Heinrich Sticht, et al. · Cellular and Molecular Life Sciences · 146

Evidence for a time-dependent association between FOLR1 expression and survival from ovarian carcinoma: implications for clinical testing. An Ovarian Tumour Tissue Analysis consortium study

2014 · AOCS Study Group, M Köbel, et al. · British Journal of Cancer · 110

PDF

Role of tumour-free margin distance for loco-regional control in vulvar cancer—a subset analysis of the Arbeitsgemeinschaft Gynäkologische Onkologie CaRE-1 multicenter study

2016 · Linn Woelber, Lis-Femke Griebel, et al. · European Journal of Cancer · 103

Association of complementary methods with quality of life and life satisfaction in patients with gynecologic and breast malignancies

2007 · P. A. Fasching, F. Thiel, et al. · Supportive Care in Cancer · 98

Reactivation of codogenic endogenous retroviral (ERV) envelope genes in human endometrial carcinoma and prestages: Emergence of new molecular targets

2012 · Pamela L. Strissel, Matthias Ruebner, et al. · Oncotarget · 88

PDF

Role of genetic polymorphisms and ovarian cancer susceptibility

2009 · Peter A. Fasching, Simon Gayther, et al. · Molecular Oncology · 83

PDF

Low-Grade Endometrial Stromal Sarcoma - a Review

2018 · Falk C. Thiel, Sonja Halmen · Oncology Research and Treatment · 80

PDF

Temsirolimus in women with platinum-refractory/resistant ovarian cancer or advanced/recurrent endometrial carcinoma. A phase II study of the AGO-study group (AGO-GYN8)

2015 · Günter Emons, Christian Kurzeder, et al. · Gynecologic Oncology · 72

Common alleles in candidate susceptibility genes associated with risk and development of epithelial ovarian cancer

2010 · Maria Notaridou, Lydia Quaye, et al. · International Journal of Cancer · 64

Sarcoma of the Uterus. Guideline of the DGGG (S2k-Level, AWMF Registry No. 015/074, August 2015)

2015 · D. Denschlag, F. Thiel, et al. · Geburtshilfe und Frauenheilkunde · 63

PDF

Knowledge and attitudes regarding medical research studies among patients with breast cancer and gynecological diseases

2015 · Michael P. Lux, Thomas Hildebrandt, et al. · BMC Cancer · 63

PDF

Hysterectomy

2010 · Andreas Müller, Falk C. Thiel, et al. · Deutsches Ärzteblatt international · 60

The era of centers: the influence of establishing specialized centers on patients’ choice of hospital

2010 · Michael Patrick Lux, P. A. Fasching, et al. · Archives of Gynecology and Obstetrics · 52

Outcome After Sentinel Lymph Node Dissection in Vulvar Cancer: A Subgroup Analysis of the AGO-CaRE-1 Study

2016 · Rüdiger Klapdor, Peter Hillemanns, et al. · Annals of Surgical Oncology · 43

Early aberrant insulin‐like growth factor signaling in the progression to endometrial carcinoma is augmented by tamoxifen

2008 · Pamela L. Strissel, Stephan Ellmann, et al. · International Journal of Cancer · 42

Phase II study of fulvestrant 250mg/month in patients with recurrent or metastatic endometrial cancer: A study of the Arbeitsgemeinschaft Gynäkologische Onkologie

2013 · Günter Emons, Andreas Günthert, et al. · Gynecologic Oncology · 40

Risk Factors for Endometriosis in a German Case–Control Study

2011 · S. Burghaus, P. Klingsiek, et al. · Geburtshilfe und Frauenheilkunde · 40

PDF

Comparison of total laparoscopic hysterectomy (TLH) and laparoscopy-assisted supracervical hysterectomy (LASH) in women with uterine leiomyoma

2009 · Andreas Mueller, Stefan P. Renner, et al. · European Journal of Obstetrics & Gynecology and Reproductive Biology · 40

Endometriosis as a risk factor for ovarian or endometrial cancer — results of a hospital-based case–control study

2015 · Stefanie Burghaus, Lothar Häberle, et al. · BMC Cancer · 36

PDF

Sarcoma of the Uterus. Guideline of the DGGG and OEGGG (S2k Level, AWMF Register Number 015/074, February 2019)

2019 · Dominik Denschlag, Sven Ackermann, et al. · Geburtshilfe und Frauenheilkunde · 35

The Hohl instrument for optimizing total laparoscopic hysterectomy: results of more than 500 procedures in a university training center

2011 · Andreas Mueller, Alexander Boosz, et al. · Archives of Gynecology and Obstetrics · 31

Works count: 151

Citation count: 3,010

H-index: 29

I10-index: 51